Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics
PHASE4CompletedINTERVENTIONAL
Enrollment
85
Participants
Timeline
Start Date
October 31, 2012
Primary Completion Date
August 31, 2014
Study Completion Date
June 30, 2015
Conditions
Insulin SecretionInsulin Resistance
Interventions
DRUG
Sitagliptin
Sitagliptin 100 mg QD for 12 weeks
Trial Locations (1)
Unknown
Fuwai Hospital, Beijing
All Listed Sponsors
lead
Guangwei Li
OTHER
NCT01610154 - Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics | Biotech Hunter | Biotech Hunter